AMGN | AmgenNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$461.26
-$4.19 (-0.90%)

Amgen (AMGN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Nov 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $461.26 vs 50 $420.83 / 200 $376.12
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Nov 2025 ยท projected 29 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $466.01 vs 50 $368.15 / 200 $302.92
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
above both $463.46 vs 50 $430.73 / 200 $400.02
Projection
No cross projected
Test
No active test
Last cross
Golden cross 9 Jul 2026 bar 1 ยท projected 28 bars out ยท tested 3 bars

Cross history

32
crosses on record since 2018
16 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
9 Jul 2026Golden4-hour28 bars out3 bar cross test
28 Apr 2026Death4-hour20 bars out2 bar cross test
13 Nov 2025Golden moderatedaily29 bars outNot tested
23 Oct 2025Golden4-hour24 bars out5 bar cross test
2 Oct 2025Death moderatedaily25 bars out1 bar cross test

About AMGN

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$1B
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmega

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.